Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase)

JOURNAL ARTICLE published March 2008 in Biologics: Targets & Therapy

Authors: Andrea Pession